Nelson Chao, MD, MBA, has served as the chief for the Division of Cellular Therapy since 1996, and for the expanded Division of Hematologic Malignancies & Cellular Therapy since 2013. At the same time, Dr. Chao also has served as leader of the Hematologic Malignancies & Cellular Therapy Research Program for the Duke Cancer Institute (DCI).
Kathleen Cooney, MD, chair of the Department of Medicine, has agreed to serve as a member of the Board of Scientific Consultants of Memorial Sloan Kettering Cancer Center.
The Duke Office of Licensing and Ventures has recognized 31 women who are innovative, collaborative, forward-thinking, and strong leaders on the cutting edge of technology and therapeutics. Among them are five faculty from the Department of Medicine: Martha Adams, MD; Kim Blackwell, MD; Kathleen Cooney, MD; Jennifer Freedman, MD; and Lori Orlando, MD.
The Duke Center for Applied Genomics & Precision Medicine will host Kathleen Cooney, MD, chair of the Department of Medicine, at its forum from 12-1 p.m. on Thursday, March 7 in DMP 2W96.
Dean Mary Klotman, MD, has announced today that Kathleen Cooney, MD, will be the new chair of the Department of Medicine, effective Aug. 1, 2018.